{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T07:52:39Z","timestamp":1781423559734,"version":"3.54.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03DA053541"],"award-info":[{"award-number":["R03DA053541"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Opioid tapering in the general population is linked to increases in hospitalizations or emergency department visits related to psychiatric or drug-related diagnoses. Cancer survivors represent a unique population with different opioid indications, prescription patterns, and more frequent follow-up care. This study sought to describe patterns of opioid tapering among older cancer survivors and to test the hypothesis of whether older cancer survivors face increased risks of adverse events with opioid tapering.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using the Surveillance, Epidemiology and End Results Medicare\u2013linked database, we identified 15\u200a002 Medicare-beneficiary cancer survivors diagnosed between 2010 and 2017 prescribed opioids consistently for at least 6 months after their cancer diagnosis. Tapering was defined as a binary time-varying event occurring with any monthly oral morphine equivalent reduction of 15% or more from the previous month. Primary diagnostic billing codes associated with emergency room or hospital admissions were used for the composite endpoint of psychiatric- or drug-related event(s).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There were 3.86 events per 100 patient-months, with 97.8% events being mental health emergencies, 1.91% events being overdose emergencies, and 0.25% involving both. Using a generalized estimating equation for repeated measure time-based analysis, opioid tapering was not statistically associated with acute events in the 3-month posttaper period (odds ratio [OR] = 1.02; P\u2009=\u2009.62) or at any point in the future (OR = 0.96; P\u2009=\u2009.46).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Opioid tapering in older cancer survivors does not appear to be linked to a higher risk of acute psychiatric- or drug-related events, in contrast to prior research in the general population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jnci\/djad241","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T18:14:56Z","timestamp":1700158496000},"page":"606-612","source":"Crossref","is-referenced-by-count":3,"title":["Opioid tapering in older cancer survivors does not increase psychiatric or drug hospitalization rates"],"prefix":"10.1093","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7966-3090","authenticated-orcid":false,"given":"Paul","family":"Riviere","sequence":"first","affiliation":[{"name":"Department of Radiation Medicine and Applied Sciences, University of California San Diego , La Jolla, CA, USA"},{"name":"Center for Health Equity and Education Research, University of California San Diego , La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2776-2721","authenticated-orcid":false,"given":"Kylie M","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Radiation Medicine and Applied Sciences, University of California San Diego , La Jolla, CA, USA"},{"name":"Center for Health Equity and Education Research, University of California San Diego , La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah N","family":"Deshler","sequence":"additional","affiliation":[{"name":"Department of Radiation Medicine and Applied Sciences, University of California San Diego , La Jolla, CA, USA"},{"name":"Center for Health Equity and Education Research, University of California San Diego , La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Radiation Medicine and Applied Sciences, University of California San Diego , La Jolla, CA, USA"},{"name":"Division of Biostatistics and Bioinformatics, Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego , La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3909-3318","authenticated-orcid":false,"given":"Carla","family":"Marienfeld","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California San Diego , La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J","family":"Coyne","sequence":"additional","affiliation":[{"name":"Department of Radiation Medicine and Applied Sciences, University of California San Diego , La Jolla, CA, USA"},{"name":"Department of Emergency Medicine, University of California San Diego , La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent S","family":"Rose","sequence":"additional","affiliation":[{"name":"Center for Health Equity and Education Research, University of California San Diego , La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Radiation Medicine and Applied Sciences, University of California San Diego , La Jolla, CA, USA"},{"name":"Center for Health Equity and Education Research, University of California San Diego , La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"issue":"7","key":"2024040509034428100_djad241-B1","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1158\/1055-9965.EPI-16-0133","article-title":"Anticipating the \u201cSilver Tsunami\u201d: prevalence trajectories and comorbidity burden among older cancer survivors in the United States","volume":"25","author":"Bluethmann","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"2024040509034428100_djad241-B2","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/jnci\/djac158","article-title":"Estimation of the number of individuals living with metastatic cancer in the United States","volume":"114","author":"Gallicchio","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"2024040509034428100_djad241-B3","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.2147\/CMAR.S355653","article-title":"A comprehensive analysis of the cancer chronic pain experience: a narrative review","volume":"14","author":"Filipponi","year":"2022","journal-title":"Cancer Manag Res"},{"issue":"1","key":"2024040509034428100_djad241-B4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/j.pain.0000000000001363","article-title":"The IASP classification of chronic pain for ICD-11: Chronic cancer-related pain","volume":"160","author":"Bennett","year":"2019","journal-title":"Pain"},{"issue":"8","key":"2024040509034428100_djad241-B5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1200\/JOP.2016.014837","article-title":"Management of chronic pain in survivors of adult cancers: ASCO clinical practice guideline summary","volume":"12","author":"Paice","year":"2016","journal-title":"JOP"},{"issue":"12","key":"2024040509034428100_djad241-B6","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/annonc\/mdn419","article-title":"Prevalence of undertreatment in cancer pain. a review of published literature","volume":"19","author":"Deandrea","year":"2008","journal-title":"Ann Oncol"},{"issue":"16","key":"2024040509034428100_djad241-B7","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1200\/JClinOncol.2011.39.2381","article-title":"Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer","volume":"30","author":"Fisch","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"2024040509034428100_djad241-B8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jpainsymman.2017.02.018","article-title":"Impact of undertreatment of cancer pain with analgesic drugs on patient outcomes: a nationwide survey of outpatient cancer patient care in Taiwan","volume":"54","author":"Shen","year":"2017","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"2024040509034428100_djad241-B9","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1001\/jamaoncol.2020.0779","article-title":"Managing cancer pain during the opioid epidemic-balancing caution and compassion","volume":"6","author":"Vitzthum","year":"2020","journal-title":"JAMA Oncol"},{"issue":"4","key":"2024040509034428100_djad241-B10","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1200\/JClinOncol.22.02198","article-title":"Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline","volume":"41","author":"Paice","year":"2023","journal-title":"J Clin Oncol"},{"issue":"5","key":"2024040509034428100_djad241-B11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/jama.2021.11013","article-title":"Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids","volume":"326","author":"Agnoli","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"2024040509034428100_djad241-B12","doi-asserted-by":"publisher","first-page":"e2216726","DOI":"10.1001\/jamanetworkopen.2022.16726","article-title":"Long-term risk of overdose or mental health crisis after opioid dose tapering","volume":"5","author":"Fenton","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2024040509034428100_djad241-B13","author":"National Cancer Institute. Age and Cancer Risk","year":"2021"},{"issue":"7","key":"2024040509034428100_djad241-B14","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/jnci\/djz200","article-title":"Predicting persistent opioid use, abuse and toxicity among cancer survivors","volume":"112","author":"Vitzthum","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"2024040509034428100_djad241-B15","doi-asserted-by":"publisher","first-page":"e204514","DOI":"10.1001\/jamanetworkopen.2020.4514","article-title":"Indication-specific opioid prescribing for US patients with medicaid or private insurance, 2017","volume":"3","author":"Mikosz","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"12","key":"2024040509034428100_djad241-B16","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1200\/JClinOncol.18.00938","article-title":"Trends in opioid use among older survivors of colorectal, lung, and breast cancers","volume":"37","author":"Salz","year":"2019","journal-title":"J Clin Oncol"},{"key":"2024040509034428100_djad241-B17","author":"U.S. Department of Health and Human Services, Centers for Medicare & Medicaid Services (CMS)"},{"issue":"5","key":"2024040509034428100_djad241-B18","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1213\/ANE.0000000000002496","article-title":"Risk factors for opioid-use disorder and overdose","volume":"125","author":"Webster","year":"2017","journal-title":"Anesth Analg"},{"key":"2024040509034428100_djad241-B19","volume-title":"Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models","author":"Vittinghoff","year":"2005"},{"key":"2024040509034428100_djad241-B20","doi-asserted-by":"crossref","DOI":"10.1002\/9781119513469","volume-title":"Applied Longitudinal Analysis","author":"Fitzmaurice","year":"2011","edition":"2nd ed."},{"key":"2024040509034428100_djad241-B21","volume-title":"Modeling Longitudinal Data","author":"Weiss","year":"2005"},{"key":"2024040509034428100_djad241-B22","author":"R: A Language and Environment for Statistical Computing V. 4.3.1","year":"2021"},{"issue":"2","key":"2024040509034428100_djad241-B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v015.i02","article-title":"The R Package geepack for Generalized Estimating Equations","volume":"15","author":"Halekoh","year":"2006","journal-title":"J Stat Softw"},{"issue":"36","key":"2024040509034428100_djad241-B24","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1200\/JClinOncol.2017.74.1363","article-title":"New persistent opioid use among patients with cancer after curative-intent surgery","volume":"35","author":"Lee","year":"2017","journal-title":"J Clin Oncol"},{"issue":"5","key":"2024040509034428100_djad241-B25","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1001\/jamaoncol.2019.0042","article-title":"US national trends in opioid-related hospitalizations among patients with cancer","volume":"5","author":"Chua","year":"2019","journal-title":"JAMA Oncol"},{"issue":"9","key":"2024040509034428100_djad241-B26","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/jnci\/djz233","article-title":"Emergency department visits for opioid overdoses among patients with cancer","volume":"112","author":"Jairam","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2024040509034428100_djad241-B27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.7326\/M19-1488","article-title":"Rethinking opioid dose tapering, prescription opioid dependence, and indications for buprenorphine","volume":"171","author":"Chou","year":"2019","journal-title":"Ann Intern Med"},{"issue":"10182","key":"2024040509034428100_djad241-B28","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","article-title":"Management of opioid use disorder in the USA: present status and future directions","volume":"393","author":"Blanco","year":"2019","journal-title":"Lancet"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djad241\/54532579\/djad241.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/116\/4\/606\/57164420\/djad241.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/116\/4\/606\/57164420\/djad241.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T09:59:06Z","timestamp":1712311146000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/116\/4\/606\/7424714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,11,16]]},"published-print":{"date-parts":[[2024,4,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djad241","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4,1]]},"published":{"date-parts":[[2023,11,16]]}}}